CTO/VP Apps Affinity Group


Chief Technology Officers and VPs of Apps share ownership of the health system’s emerging digital platform and ecosystem of apps that support the digitally-enabled, consumer-centered and equitable health system of the future. Via Dialogue calls and virtual Summits, the SI CTO/VP Apps Affinity Group offers leaders a forum to innovate on topics such as optimizing service delivery, fine-tuning virtual tools post-COVID, strengthening telework strategies, managing vendors/3rd-party relationships, defining mobility uses/best practices and much more.

Dialogue Calls

These 1-hour, peer-led Zoom meetings are by invitation-only, with recaps distributed to attendees.

Request to join Affinity Group

    I am requesting to join the below Affinity Groups:

    Guest-Lead/Host a DialogueTo guest-lead/host one of our Dialogues, please contact us to share topics for discussion.
    Create a Profile to attendPlease take two minutes to create an SI profile to gain access to member-only events and content. Specify which topics are of most interest to you, thereby customizing your notifications and news to fit your busy schedule.

    CTO/VP Apps Dialogues


    CTO/VP Apps Roundtables

    There are no upcoming CTO/VP Apps Roundtables at this time.

    CTO/VP Apps Summits

    There are no upcoming CTO/VP Apps Summits at this time.

    CTO/VP Apps Webinars

    Open to all members

    About Affinity Groups

    SI Affinity Groups are intimate forums focused on a common issue, topic or collective challenge of its members, with a goal of information sharing around similar concerns, best practices, lessons learned, industry trends and resources to help organizations thrive.

    CTO/VP Apps Publications

    Renato Umeton, PhD
    Associate Director of Artificial Intelligence Operations and Data Science Services, Informatics & Analytics Dept., Dana-Farber Cancer Institute, teaching affiliates of: Harvard Medical School, Harvard T.H. Chan School of Public Health, Massachusetts Institute of Technology, Weill Cornell Medicine
    "I continue to be impressed by the quality of the material presented by SI collaborators, the last two sessions I attended were both exquisite."